O	O	0	11	Recombinant	Recombinant	B-NP	JJ	O	2	NMOD	O
T1	B-Protein	12	17	NFAT1	NFAT1	I-NP	NN	B-protein	6	SUB	B-protein
O	O	18	19	(	(	O	(	O	5	DEP	O
T2	B-Protein	19	24	NFATp	NFATp	B-NP	NN	B-protein	5	DEP	B-protein
O	O	24	25	)	)	O	)	O	2	NMOD	O
O	O	26	28	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	29	38	regulated	regulate	I-VP	VBN	O	6	VC	O
O	O	39	41	by	by	B-PP	IN	O	7	VMOD	O
T16	B-Entity	42	53	calcineurin	calcineurin	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	54	56	in	in	B-PP	IN	O	7	VMOD	O
O	O	57	58	T	T	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	59	64	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	65	68	and	and	O	CC	O	6	VMOD	O
O	O	69	77	mediates	mediate	B-VP	VBZ	O	6	VMOD	O
O	O	78	91	transcription	transcription	B-NP	NN	O	14	OBJ	O
O	O	92	94	of	of	B-PP	IN	O	15	NMOD	O
O	O	95	102	several	several	B-NP	JJ	O	19	NMOD	O
T17	B-Entity	103	111	cytokine	cytokine	I-NP	NN	B-DNA	19	NMOD	B-DNA
T17	I-Entity	112	117	genes	gene	I-NP	NNS	I-DNA	16	PMOD	I-DNA
O	O	117	118	.	.	O	.	O	6	P	O

O	O	120	133	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	134	141	factors	factor	I-NP	NNS	I-protein	7	SUB	I-protein
O	O	142	144	of	of	B-PP	IN	O	2	NMOD	O
O	O	145	148	the	the	B-NP	DT	O	6	NMOD	O
O	O	149	153	NFAT	NFAT	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	154	160	family	family	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	161	165	play	play	B-VP	VBP	O	0	ROOT	O
O	O	166	167	a	a	B-NP	DT	O	10	NMOD	O
O	O	168	171	key	key	I-NP	JJ	O	10	NMOD	O
O	O	172	176	role	role	I-NP	NN	O	7	OBJ	O
O	O	177	179	in	in	B-PP	IN	O	7	VMOD	O
O	O	180	183	the	the	B-NP	DT	O	13	NMOD	O
O	O	184	197	transcription	transcription	I-NP	NN	O	11	PMOD	O
O	O	198	200	of	of	B-PP	IN	O	13	NMOD	O
T18	B-Entity	201	209	cytokine	cytokine	B-NP	NN	B-DNA	16	NMOD	B-DNA
T18	I-Entity	210	215	genes	gene	I-NP	NNS	I-DNA	19	NMOD	I-DNA
O	O	216	219	and	and	O	CC	O	19	NMOD	O
O	O	220	225	other	other	B-NP	JJ	O	19	NMOD	O
T19	B-Entity	226	231	genes	gene	I-NP	NNS	O	14	PMOD	O
O	O	232	238	during	during	B-PP	IN	O	7	VMOD	O
O	O	239	242	the	the	B-NP	DT	O	23	NMOD	O
O	O	243	249	immune	immune	I-NP	JJ	O	23	NMOD	O
O	O	250	258	response	response	I-NP	NN	O	20	PMOD	O
O	O	258	259	.	.	O	.	O	7	P	O

O	O	260	262	We	We	B-NP	PRP	O	2	SUB	O
O	O	263	267	have	have	B-VP	VBP	O	0	ROOT	O
O	O	268	278	identified	identify	I-VP	VBN	O	2	VC	O
O	O	279	282	two	two	B-NP	CD	O	6	NMOD	O
O	O	283	286	new	new	I-NP	JJ	O	6	NMOD	O
O	O	287	295	isoforms	isoform	I-NP	NNS	O	3	OBJ	O
O	O	296	298	of	of	B-PP	IN	O	6	NMOD	O
O	O	299	302	the	the	B-NP	DT	O	11	NMOD	O
O	O	303	316	transcription	transcription	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	317	323	factor	factor	I-NP	NN	I-protein	11	NMOD	I-protein
T3	B-Protein	324	329	NFAT1	NFAT1	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	330	331	(	(	O	(	O	11	NMOD	O
O	O	331	341	previously	previously	B-NP	RB	O	14	VMOD	O
O	O	342	348	termed	term	I-NP	VBN	O	11	NMOD	O
T4	B-Protein	349	354	NFATp	NFATp	I-NP	NN	B-protein	14	VMOD	B-protein
O	O	354	355	)	)	O	)	O	11	NMOD	O
O	O	356	360	that	that	B-NP	WDT	O	6	NMOD	O
O	O	361	364	are	be	B-VP	VBP	O	17	SBAR	O
O	O	365	368	the	the	B-NP	DT	O	21	NMOD	O
O	O	369	380	predominant	predominant	I-NP	JJ	O	21	NMOD	O
O	O	381	389	isoforms	isoform	I-NP	NNS	O	18	PRD	O
O	O	390	399	expressed	express	B-VP	VBN	O	21	NMOD	O
O	O	400	402	in	in	B-PP	IN	O	22	VMOD	O
O	O	403	409	murine	murine	B-NP	JJ	B-cell_type	28	NMOD	B-cell_type
O	O	410	413	and	and	I-NP	CC	I-cell_type	28	NMOD	I-cell_type
O	O	414	419	human	human	I-NP	JJ	I-cell_type	28	NMOD	I-cell_type
O	O	420	421	T	T	I-NP	NN	I-cell_type	28	NMOD	I-cell_type
O	O	422	427	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	427	428	.	.	O	.	O	2	P	O

O	O	429	433	When	When	B-ADVP	WRB	O	27	VMOD	O
O	O	434	443	expressed	express	B-VP	VBN	O	1	SBAR	O
O	O	444	446	in	in	B-PP	IN	O	2	VMOD	O
O	O	447	453	Jurkat	Jurkat	B-NP	NN	B-cell_line	6	NMOD	B-cell_line
O	O	454	455	T	T	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	456	461	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	461	462	,	,	O	,	O	27	P	O
O	O	463	474	recombinant	recombinant	B-NP	JJ	O	9	NMOD	O
T5	B-Protein	475	480	NFAT1	NFAT1	I-NP	NN	B-protein	10	SUB	B-protein
O	O	481	483	is	be	B-VP	VBZ	O	27	VMOD	O
O	O	484	493	regulated	regulate	I-VP	VBN	O	10	VC	O
O	O	493	494	,	,	O	,	O	11	P	O
O	O	495	497	as	as	B-SBAR	IN	O	11	VMOD	O
O	O	498	506	expected	expect	B-VP	VBN	O	13	SBAR	O
O	O	506	507	,	,	O	,	O	11	P	O
O	O	508	510	by	by	B-PP	IN	O	11	VMOD	O
O	O	511	514	the	the	B-NP	DT	O	22	NMOD	O
T6	B-Protein	515	525	calmodulin	calmodulin	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	525	526	-	-	B-NP	HYPH	O	22	NMOD	O
O	O	526	535	dependent	dependent	I-NP	JJ	O	22	NMOD	O
O	O	536	547	phosphatase	phosphatase	I-NP	NN	O	22	NMOD	O
T20	B-Entity	548	559	calcineurin	calcineurin	I-NP	NN	B-protein	16	PMOD	B-protein
O	O	559	560	,	,	O	,	O	27	P	O
O	O	561	564	and	and	O	CC	O	27	VMOD	O
O	O	565	568	its	its	B-NP	PRP$	O	26	NMOD	O
O	O	569	577	function	function	I-NP	NN	O	27	SUB	O
O	O	578	580	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	581	590	inhibited	inhibit	I-VP	VBN	O	27	VC	O
O	O	591	593	by	by	B-PP	IN	O	28	VMOD	O
O	O	594	597	the	the	B-NP	DT	O	32	NMOD	O
O	O	598	615	immunosuppressive	immunosuppressive	I-NP	JJ	O	32	NMOD	O
O	O	616	621	agent	agent	I-NP	NN	O	34	NMOD	O
O	O	622	633	cyclosporin	cyclosporin	I-NP	NN	O	34	NMOD	O
O	O	634	635	A	A	I-NP	NN	O	29	PMOD	O
O	O	636	637	(	(	O	(	O	37	DEP	O
O	O	637	640	CsA	CsA	B-NP	NN	O	37	DEP	O
O	O	640	641	)	)	O	)	O	34	NMOD	O
O	O	641	642	.	.	O	.	O	27	P	O

O	O	643	658	Transactivation	Transactivation	B-NP	NN	O	9	SUB	O
O	O	659	661	by	by	B-PP	IN	O	1	NMOD	O
O	O	662	673	recombinant	recombinant	B-NP	JJ	O	4	NMOD	O
T7	B-Protein	674	679	NFAT1	NFAT1	I-NP	NN	B-protein	2	PMOD	B-protein
O	O	680	682	in	in	B-PP	IN	O	1	NMOD	O
O	O	683	689	Jurkat	Jurkat	B-NP	NN	B-cell_line	8	NMOD	B-cell_line
O	O	690	691	T	T	I-NP	NN	I-cell_line	8	NMOD	I-cell_line
O	O	692	697	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	698	706	requires	require	B-VP	VBZ	O	25	VMOD	O
O	O	707	711	dual	dual	B-NP	JJ	O	11	NMOD	O
O	O	712	723	stimulation	stimulation	I-NP	NN	O	9	OBJ	O
O	O	724	728	with	with	B-PP	IN	O	11	NMOD	O
O	O	729	738	ionomycin	ionomycin	B-NP	NN	O	21	NMOD	O
O	O	739	742	and	and	O	CC	O	21	NMOD	O
O	O	743	750	phorbol	phorbol	B-NP	NN	O	21	NMOD	O
O	O	751	753	12	12	I-NP	CD	O	15	NMOD	O
O	O	753	754	-	-	O	HYPH	O	21	NMOD	O
O	O	754	763	myristate	myristate	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	764	766	13	13	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	766	767	-	-	I-NP	HYPH	O	18	P	O
O	O	767	774	acetate	acetate	I-NP	NN	O	12	PMOD	O
O	O	774	775	;	;	O	:	O	9	P	O
O	O	776	780	this	this	B-NP	DT	O	24	NMOD	O
O	O	781	789	activity	activity	I-NP	NN	O	25	SUB	O
O	O	790	792	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	793	804	potentiated	potentiate	I-VP	VBN	O	25	VC	O
O	O	805	807	by	by	B-PP	IN	O	26	VMOD	O
O	O	808	820	coexpression	coexpression	B-NP	NN	O	27	PMOD	O
O	O	821	823	of	of	B-PP	IN	O	28	NMOD	O
O	O	824	838	constitutively	constitutively	B-NP	RB	O	31	AMOD	O
O	O	839	845	active	active	I-NP	JJ	O	32	NMOD	O
T21	B-Entity	846	857	calcineurin	calcineurin	I-NP	NN	B-protein	29	PMOD	B-protein
O	O	858	861	and	and	O	CC	O	25	VMOD	O
O	O	862	864	is	be	B-VP	VBZ	O	25	VMOD	O
O	O	865	874	inhibited	inhibit	I-VP	VBN	O	34	VC	O
O	O	875	877	by	by	B-PP	IN	O	35	VMOD	O
O	O	878	881	CsA	CsA	B-NP	NN	O	36	PMOD	O
O	O	881	882	.	.	O	.	O	25	P	O

O	O	883	901	Immunocytochemical	Immunocytochemical	B-NP	JJ	O	2	NMOD	O
O	O	902	910	analysis	analysis	I-NP	NN	O	3	SUB	O
O	O	911	920	indicates	indicate	B-VP	VBZ	O	0	ROOT	O
O	O	921	925	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	926	937	recombinant	recombinant	B-NP	JJ	O	6	NMOD	O
T8	B-Protein	938	943	NFAT1	NFAT1	I-NP	NN	B-protein	7	SUB	B-protein
O	O	944	953	localizes	localize	B-VP	VBZ	O	4	SBAR	O
O	O	954	956	in	in	B-PP	IN	O	7	VMOD	O
O	O	957	960	the	the	B-NP	DT	O	10	NMOD	O
O	O	961	970	cytoplasm	cytoplasm	I-NP	NN	O	8	PMOD	O
O	O	971	973	of	of	B-PP	IN	O	10	NMOD	O
O	O	974	985	transiently	transiently	B-NP	RB	O	13	AMOD	O
O	O	986	997	transfected	transfecte	I-NP	VBN	O	15	NMOD	O
O	O	998	999	T	T	I-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	1000	1005	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	1006	1009	and	and	O	CC	O	7	VMOD	O
O	O	1010	1022	translocates	translocate	B-VP	VBZ	O	7	VMOD	O
O	O	1023	1027	into	into	B-PP	IN	O	17	VMOD	O
O	O	1028	1031	the	the	B-NP	DT	O	20	NMOD	O
O	O	1032	1039	nucleus	nucleus	I-NP	NN	O	18	PMOD	O
O	O	1040	1042	in	in	B-PP	IN	O	17	VMOD	O
O	O	1043	1044	a	a	B-NP	DT	O	26	NMOD	O
O	O	1045	1048	CsA	CsA	I-NP	NN	O	26	NMOD	O
O	O	1048	1049	-	-	B-NP	HYPH	O	26	P	O
O	O	1049	1058	sensitive	sensitive	I-NP	JJ	O	26	NMOD	O
O	O	1059	1065	manner	manner	I-NP	NN	O	21	PMOD	O
O	O	1066	1075	following	follow	B-PP	VBG	O	17	VMOD	O
O	O	1076	1085	ionomycin	ionomycin	B-NP	NN	O	29	NMOD	O
O	O	1086	1097	stimulation	stimulation	I-NP	NN	O	27	PMOD	O
O	O	1097	1098	.	.	O	.	O	3	P	O

O	O	1099	1103	When	When	B-ADVP	WRB	O	10	VMOD	O
O	O	1104	1113	expressed	express	B-VP	VBN	O	1	SBAR	O
O	O	1114	1116	in	in	B-PP	IN	O	2	VMOD	O
O	O	1117	1120	COS	COS	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	1121	1126	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	1126	1127	,	,	O	,	O	10	P	O
O	O	1128	1135	however	however	B-ADVP	RB	O	10	VMOD	O
O	O	1135	1136	,	,	O	,	O	10	P	O
T9	B-Protein	1137	1142	NFAT1	NFAT1	B-NP	NN	B-protein	10	SUB	B-protein
O	O	1143	1145	is	be	B-VP	VBZ	O	17	VMOD	O
O	O	1146	1153	capable	capable	B-ADJP	JJ	O	10	PRD	O
O	O	1154	1156	of	of	B-PP	IN	O	11	AMOD	O
O	O	1157	1172	transactivation	transactivation	B-NP	NN	O	12	PMOD	O
O	O	1172	1173	,	,	O	,	O	17	P	O
O	O	1174	1177	but	but	O	CC	O	17	VMOD	O
O	O	1178	1180	it	it	B-NP	PRP	O	17	SUB	O
O	O	1181	1183	is	be	B-VP	VBZ	O	28	VMOD	O
O	O	1184	1187	not	not	I-VP	RB	O	17	VMOD	O
O	O	1188	1197	regulated	regulate	I-VP	VBN	O	17	VC	O
O	O	1198	1207	correctly	correctly	B-ADVP	RB	O	19	VMOD	O
O	O	1207	1208	:	:	O	:	O	17	P	O
O	O	1209	1212	its	its	B-NP	PRP$	O	24	NMOD	O
O	O	1213	1224	subcellular	subcellular	I-NP	JJ	O	24	NMOD	O
O	O	1225	1237	localization	localization	I-NP	NN	O	28	SUB	O
O	O	1238	1241	and	and	O	CC	O	27	NMOD	O
O	O	1242	1257	transcriptional	transcriptional	B-NP	JJ	O	27	NMOD	O
O	O	1258	1266	function	function	I-NP	NN	O	24	NMOD	O
O	O	1267	1270	are	be	B-VP	VBP	O	0	ROOT	O
O	O	1271	1274	not	not	I-VP	RB	O	28	VMOD	O
O	O	1275	1283	affected	affect	I-VP	VBN	O	28	VC	O
O	O	1284	1286	by	by	B-PP	IN	O	30	VMOD	O
O	O	1287	1298	stimulation	stimulation	B-NP	NN	O	31	PMOD	O
O	O	1299	1301	of	of	B-PP	IN	O	32	NMOD	O
O	O	1302	1305	the	the	B-NP	DT	O	36	NMOD	O
O	O	1306	1309	COS	COS	I-NP	NN	B-cell_line	36	NMOD	B-cell_line
O	O	1310	1315	cells	cell	I-NP	NNS	I-cell_line	33	PMOD	I-cell_line
O	O	1316	1320	with	with	B-PP	IN	O	32	NMOD	O
O	O	1321	1330	ionomycin	ionomycin	B-NP	NN	O	46	NMOD	O
O	O	1331	1334	and	and	O	CC	O	46	NMOD	O
O	O	1335	1342	phorbol	phorbol	B-NP	NN	O	46	NMOD	O
O	O	1343	1345	12	12	I-NP	CD	O	40	NMOD	O
O	O	1345	1346	-	-	O	HYPH	O	46	NMOD	O
O	O	1346	1355	myristate	myristate	B-NP	NN	B-protein	46	NMOD	B-protein
O	O	1356	1358	13	13	I-NP	CD	I-protein	43	NMOD	I-protein
O	O	1358	1359	-	-	I-NP	HYPH	O	43	P	O
O	O	1359	1366	acetate	acetate	I-NP	NN	O	37	PMOD	O
O	O	1366	1367	.	.	O	.	O	28	P	O

O	O	1368	1379	Recombinant	Recombinant	B-NP	JJ	O	2	NMOD	O
T10	B-Protein	1380	1385	NFAT1	NFAT1	I-NP	NN	B-protein	3	SUB	B-protein
O	O	1386	1389	can	can	B-VP	MD	O	0	ROOT	O
O	O	1390	1397	mediate	mediate	I-VP	VB	O	3	VC	O
O	O	1398	1411	transcription	transcription	B-NP	NN	O	4	OBJ	O
O	O	1412	1414	of	of	B-PP	IN	O	5	NMOD	O
O	O	1415	1418	the	the	B-NP	DT	O	9	NMOD	O
T11	B-Protein	1419	1430	interleukin	interleukin	I-NP	NN	B-protein	9	NMOD	B-protein
T11	I-Protein	1430	1431	-	-	O	HYPH	I-protein	19	NMOD	I-protein
T11	I-Protein	1431	1432	2	2	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	1432	1433	,	,	O	,	O	9	P	O
T12	B-Protein	1434	1445	interleukin	interleukin	B-NP	NN	B-protein	13	NMOD	B-protein
T12	I-Protein	1445	1446	-	-	O	HYPH	I-protein	9	P	I-protein
T12	I-Protein	1446	1447	4	4	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	1447	1448	,	,	O	,	O	9	P	O
T13	B-Protein	1449	1454	tumor	tumor	B-NP	NN	B-protein	19	NMOD	B-protein
T13	I-Protein	1455	1463	necrosis	necrosis	I-NP	NN	I-protein	19	NMOD	I-protein
T13	I-Protein	1464	1470	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T13	I-Protein	1471	1476	alpha	alpha	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	1476	1477	,	,	O	,	O	29	P	O
O	O	1478	1481	and	and	O	CC	O	29	NMOD	O
T14	B-Protein	1482	1493	granulocyte	granulocyte	B-NP	NN	B-cell_type	29	NMOD	B-cell_type
T14	I-Protein	1493	1494	-	-	O	HYPH	O	29	P	O
T14	I-Protein	1494	1504	macrophage	macrophage	B-NP	NN	B-DNA	29	NMOD	B-DNA
T14	I-Protein	1505	1511	colony	colony	I-NP	NN	I-DNA	29	NMOD	I-DNA
T14	I-Protein	1511	1512	-	-	O	HYPH	I-DNA	29	NMOD	I-DNA
T14	I-Protein	1512	1523	stimulating	stimulate	B-VP	VBG	I-DNA	29	NMOD	I-DNA
T14	I-Protein	1524	1530	factor	factor	B-NP	NN	I-DNA	29	NMOD	I-DNA
T22	B-Entity	1531	1540	promoters	promoter	I-NP	NNS	I-DNA	3	VMOD	I-DNA
O	O	1541	1543	in	in	B-PP	IN	O	29	NMOD	O
O	O	1544	1545	T	T	B-NP	NN	B-cell_type	32	NMOD	B-cell_type
O	O	1546	1551	cells	cell	I-NP	NNS	I-cell_type	30	PMOD	I-cell_type
O	O	1551	1552	,	,	O	,	O	29	P	O
O	O	1553	1563	suggesting	suggest	B-VP	VBG	O	29	NMOD	O
O	O	1564	1568	that	that	B-SBAR	IN	O	34	VMOD	O
T15	B-Protein	1569	1574	NFAT1	NFAT1	B-NP	NN	B-protein	37	SUB	B-protein
O	O	1575	1586	contributes	contribute	B-VP	VBZ	O	35	SBAR	O
O	O	1587	1589	to	to	B-PP	TO	O	37	VMOD	O
O	O	1590	1593	the	the	B-NP	DT	O	43	NMOD	O
O	O	1594	1597	CsA	CsA	I-NP	NN	O	43	NMOD	O
O	O	1597	1598	-	-	B-NP	HYPH	O	43	NMOD	O
O	O	1598	1607	sensitive	sensitive	I-NP	JJ	O	43	NMOD	O
O	O	1608	1621	transcription	transcription	I-NP	NN	O	38	PMOD	O
O	O	1622	1624	of	of	B-PP	IN	O	43	NMOD	O
O	O	1625	1630	these	these	B-NP	DT	O	46	NMOD	O
T23	B-Entity	1631	1636	genes	gene	I-NP	NNS	O	44	PMOD	O
O	O	1637	1643	during	during	B-PP	IN	O	43	NMOD	O
O	O	1644	1647	the	the	B-NP	DT	O	50	NMOD	O
O	O	1648	1654	immune	immune	I-NP	JJ	O	50	NMOD	O
O	O	1655	1663	response	response	I-NP	NN	O	47	PMOD	O
O	O	1663	1664	.	.	O	.	O	3	P	O
